News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioReliance Corporation Announces First Commercial Use of HyMy(TM) Assay


11/20/2008 8:35:35 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance announced today the successful completion of the first commercial application of its proprietary hybrid mycoplasma (HyMy™) assay, combining the efficacy of the broth amplification method of mycoplasma detection and the speed of qPCR detection to cut the turnaround time by more than half on this vital, but lengthy assay.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES